IRIDEX Corporation (NASDAQ:IRIX) — Market Cap & Net Worth
Market Cap & Net Worth: IRIDEX Corporation (IRIX)
IRIDEX Corporation (NASDAQ:IRIX) has a market capitalization of $17.92 Million ($17.92 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25499 globally and #5329 in its home market, demonstrating a 7.21% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IRIDEX Corporation's stock price $1.19 by its total outstanding shares 17395350 (17.40 Million). Review IRIX current and long-term liabilities to assess the company's total debt and financial obligations.
IRIDEX Corporation Market Cap History: 2015 to 2026
IRIDEX Corporation's market capitalization history from 2015 to 2026. Data shows change from $161.60 Million to $20.70 Million (-16.47% CAGR).
Index Memberships
IRIDEX Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.00% | #728 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #2393 of 3165 |
Weight: IRIDEX Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
IRIDEX Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IRIDEX Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.38x
IRIDEX Corporation's market cap is 0.38 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $244.58 Million | $46.16 Million | -$11.71 Million | 5.30x | N/A |
| 2017 | $132.55 Million | $41.59 Million | -$12.87 Million | 3.19x | N/A |
| 2018 | $81.76 Million | $42.60 Million | -$12.81 Million | 1.92x | N/A |
| 2019 | $38.79 Million | $43.45 Million | -$8.81 Million | 0.89x | N/A |
| 2020 | $43.66 Million | $36.35 Million | -$6.33 Million | 1.20x | N/A |
| 2021 | $106.29 Million | $53.90 Million | -$5.22 Million | 1.97x | N/A |
| 2022 | $34.96 Million | $56.97 Million | -$7.55 Million | 0.61x | N/A |
| 2023 | $48.88 Million | $51.87 Million | -$9.57 Million | 0.94x | N/A |
| 2024 | $29.22 Million | $48.67 Million | -$8.91 Million | 0.60x | N/A |
| 2025 | $19.83 Million | $52.67 Million | -$4.44 Million | 0.38x | N/A |
Competitor Companies of IRIX by Market Capitalization
Companies near IRIDEX Corporation in the global market cap rankings as of June 18, 2026.
Key companies related to IRIDEX Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $157.58 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $118.86 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #244 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $157.58 Billion | $90.62 |
| #205 | Stryker Corporation | NYSE:SYK | $118.86 Billion | $310.58 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #244 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $81.32 |
IRIDEX Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, IRIDEX Corporation's market cap moved from $161.60 Million to $ 20.70 Million, with a yearly change of -16.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $20.70 Million | +4.39% |
| 2025 | $19.83 Million | -32.14% |
| 2024 | $29.22 Million | -40.21% |
| 2023 | $48.88 Million | +39.80% |
| 2022 | $34.96 Million | -67.10% |
| 2021 | $106.29 Million | +143.43% |
| 2020 | $43.66 Million | +12.56% |
| 2019 | $38.79 Million | -52.55% |
| 2018 | $81.76 Million | -38.32% |
| 2017 | $132.55 Million | -45.80% |
| 2016 | $244.58 Million | +51.35% |
| 2015 | $161.60 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of IRIDEX Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.92 Million USD |
| MoneyControl | $17.92 Million USD |
| MarketWatch | $17.92 Million USD |
| marketcap.company | $17.92 Million USD |
| Reuters | $17.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and Oc… Read more